Home > Boards > US Listed > Biotechs > Adamis Pharmaceuticals Corporation (ADMP)

Thanks for the balance pal! Proceed to

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
BigT82 Member Profile
 
Followed By 10
Posts 2,613
Boards Moderated 2
Alias Born 12/24/14
160x600 placeholder
Additional Proxy Soliciting Materials (definitive) (defa14a) Edgar (US Regulatory) - 6/14/2021 10:32:44 AM
Adamis Files Definitive Proxy Statement and Sends Letter to Stockholders Business Wire - 6/14/2021 9:00:00 AM
Proxy Statment - Contested Solicitations (definitive) (defc14a) Edgar (US Regulatory) - 6/14/2021 6:03:38 AM
Adamis begins clinical trial start-up activities for COVID drug; shares rise 5% Seeking Alpha - 6/11/2021 8:33:04 AM
Adamis Provides Update on Clinical Trial Start-Up Progress for Tempol in the Treatment of COVID-19 GlobeNewswire Inc. - 6/11/2021 7:30:00 AM
Adamis Pharma soars 18% after FDA accepts Zimhi application for review Seeking Alpha - 6/9/2021 7:46:12 AM
Adamis Provides Update on ZIMHI™ GlobeNewswire Inc. - 6/9/2021 7:30:00 AM
Adamis Highlights National Institute of Health Study Identifying Tempol as a Potential Antiviral Drug for COVID-19 GlobeNewswire Inc. - 6/7/2021 7:30:00 AM
Initial Statement of Beneficial Ownership (3) Edgar (US Regulatory) - 6/2/2021 5:37:32 PM
Additional Proxy Soliciting Materials - Non-management (definitive) (dfan14a) Edgar (US Regulatory) - 6/2/2021 8:20:43 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/1/2021 4:37:06 PM
Adamis Pharmaceuticals Provides Business Update GlobeNewswire Inc. - 6/1/2021 7:30:00 AM
Adamis pharmaceuticals gets deficiency letter from NASDAQ Seeking Alpha - 5/28/2021 4:09:47 PM
Adamis Pharmaceuticals Announces Receipt of Deficiency Letter from NASDAQ GlobeNewswire Inc. - 5/28/2021 4:04:00 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/27/2021 5:12:17 PM
Amended Notification That Quarterly Report Will Be Submitted Late (nt 10-q/a) Edgar (US Regulatory) - 5/24/2021 5:22:16 PM
Notification That Quarterly Report Will Be Submitted Late (nt 10-q) Edgar (US Regulatory) - 5/17/2021 4:17:20 PM
Adamis Pharmaceuticals Provides Update on First Quarter 2021 Financial Results Conference Call GlobeNewswire Inc. - 5/17/2021 4:05:00 PM
Adamis resubmits ZIMHI opioid overdose treatment NDA Seeking Alpha - 5/17/2021 7:45:45 AM
Adamis Pharmaceuticals Resubmits ZIMHI New Drug Application to FDA for the Treatment of Opioid Overdose GlobeNewswire Inc. - 5/17/2021 7:30:00 AM
Adamis Pharmaceuticals Schedules First Quarter 2021 Financial Results Conference Call and Business Update GlobeNewswire Inc. - 5/12/2021 7:30:00 AM
Amended Annual Report (10-k/a) Edgar (US Regulatory) - 4/30/2021 4:51:44 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 4/15/2021 5:04:55 PM
Annual Report (10-k) Edgar (US Regulatory) - 4/15/2021 5:04:18 PM
Adamis Pharmaceuticals misses on revenue Seeking Alpha - 4/15/2021 4:55:17 PM
BigT82   Wednesday, 05/05/21 12:56:12 PM
Re: ShortsRClowns post# 2498
Post # of 2804 
Thanks for the balance pal!

Proceed to scoop! It’s gooooo time!

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences